HIV Clinical Trial
Official title:
Immune Enhancement for Immunological Non-responders to ART
The purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV. You are being asked to volunteer because you have HIV (Human Immunodeficiency Virus) and you take anti-retroviral therapy (ART) medications.
There will be up to eleven study visits and three telephone visits. All study procedures are
for research purposes. All study subjects will receive the nutritional supplements zinc and
SAMe.
During the study you will be asked to answer questions about your alcohol use and smoking
history. You will have exhaled breath tests, blood draws, physical exams, and bronchoscopies.
Your medical records will be reviewed during the study. If you are a woman of childbearing
age, a urine pregnancy test will be done at each study visit.
Visit 1 (screening visit): This visit will last about 2 hours. At this visit you will:
- Have a physical exam
- Review your medical history
- Review your medications
- Have blood drawn
- Have a urine pregnancy test for women of child-bearing age
- Complete a survey about your alcohol use and smoking history.
- Discuss and schedule a bronchoscopy for the next visit You may not be eligible to
continue in the study if the blood work done at visit one is not within normal limits or
if you are pregnant. A study team member will contact you to let you know if you do or
do not qualify to participate in the remainder of the study.
Visit 2: This visit will last about 6 hours and will take place at the Hospital. At this
visit you will:
- Have a physical exam
- Have blood drawn
- Have a urine pregnancy test for women of child-bearing age
- Do an exhaled breath test
- Have a bronchoscopy
- Receive nutritional supplements and education
Treatment: The nutritional supplements zinc and SAMe will be given to you by the study team
at visit 2. You will be asked to take the tablets once a day.
If you experience upset stomach, abdominal cramps, diarrhea, or other uncomfortable side
effects, we will reduce the amount of the nutritional supplements. If you are unable to
tolerate the nutritional supplements, you will be withdrawn from the research study.
Visits 3, 4, and 5 -Telephone Contact: You will receive a telephone call at one, two, and
three weeks after visit 2 to ask you how you are tolerating the study supplements. If you are
experiencing side effects such as upset stomach, abdominal cramps, or diarrhea, we will
instruct you to decrease the dose of the supplements.
Visits 6, 7, and 8 (months one, two, and three): These visits will last about 30 minutes and
will be scheduled two months apart. At this visit you will:
- Have blood drawn
- Have a urine pregnancy test for women of child-bearing age
- Do an exhaled breath test
- Answer questions about how you are tolerating the nutritional supplements
- Receive nutritional supplements and education
If your exhaled breath test is at goal at visit 6, you will continue to take the dietary
supplements for one year from this point forward. If your exhaled breath test is not at goal
at visit 6, you will be asked to return for visit 7. If your exhaled breath test is at goal
at visit 7, you will continue to take the dietary supplements for one year from this point
forward. If your exhaled breath test is not at goal at visit 7, you will be asked to return
for visit 8. You will be asked to take the nutritional supplements for one year from this
point forward.
Visits 9 through 13: These visits will last about 30 minutes and will be scheduled two months
apart.
At this visit you will:
- Have blood drawn
- Have a urine pregnancy test for women of child-bearing age
- Answer questions about how you are tolerating the nutritional supplements
- Receive nutritional supplements and education
Visit 14: This is the final study visit. It will last about 6 hours and will take place at
the Hospital. At this visit you will:
- Have a physical exam
- Have blood drawn
- Have a urine pregnancy test for women of child-bearing age
- Do an exhaled breath test
- Have a bronchoscopy procedure
- Return unused nutritional supplements
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |